Cel-Sci Corporation (CVM) Covered Calls
There are no covered calls available for Cel-Sci Corporation.
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was founded in 1983 and is headquartered in Vienna, Virginia.
| Top 10 Open Interest For Jun 20 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | SLV covered calls | 1. | ALT covered calls | |
| 2. | SPY covered calls | 7. | IWM covered calls | 2. | PHAT covered calls | |
| 3. | QQQ covered calls | 8. | TLT covered calls | 3. | CAPR covered calls | |
| 4. | TSLA covered calls | 9. | AAPL covered calls | 4. | RUN covered calls | |
| 5. | GLD covered calls | 10. | INTC covered calls | 5. | GES covered calls | |
Want more examples? CVLT Covered Calls | CVNA Covered Calls
